What's Happening?
The fashion industry is witnessing a significant shift back towards extreme thinness on runways and social media, a trend that contrasts with the body positivity movement's peak in the late 2010s. Recent data from shows in four major fashion capitals
indicates that 97.5% of models wore a US ready-to-wear size 4 or smaller. An analysis by Vogue Business further supports this, showing an increase in the share of outfits displayed on smaller-sized models from 95% in 2023-2024 to 97% in the subsequent two years. This resurgence of thinness is occurring alongside increased attention on weight-loss drugs, with pharmaceutical company Eli Lilly, maker of Mounjaro and Zepbound, sponsoring events like Vogue World Milano. Organizations focused on eating disorders have criticized this association, while Eli Lilly states its aim is to shift the conversation about body weight towards health and reduce the stigmatization of obesity. Tigress Osborn, president of the US-based National Association to Advance Fat Acceptance, notes that the fashion industry has often co-opted body positivity messages for marketing without implementing substantial changes in business practices.
Why It's Important?
This shift in fashion trends carries significant implications for societal perceptions of body image and the ongoing dialogue around health and beauty standards in the U.S. The renewed emphasis on extreme thinness on influential platforms like fashion runways can exert pressure on individuals, particularly young people, to conform to unrealistic body ideals, potentially exacerbating issues related to body dissatisfaction and eating disorders. The involvement of pharmaceutical companies producing weight-loss drugs in fashion events further complicates this landscape, blurring the lines between health, aesthetics, and commercial interests. While these companies claim to promote health and reduce stigma, their association with an industry historically criticized for promoting unattainable body standards raises concerns about the potential for increased pressure to use such medications for aesthetic rather than medical reasons. This trend could undermine the progress made by the body positivity movement, which has advocated for the acceptance of diverse body shapes and sizes, and may lead to a more narrow and exclusionary definition of beauty in mainstream culture.
What's Next?
The fashion industry's trajectory suggests a continued emphasis on slender body types, potentially influencing design, marketing, and consumer expectations. The role of GLP-1 drugs, such as Ozempic, in shaping public perception of weight loss is likely to grow, with potential impacts on how body image is discussed and pursued. As noted by Amanda Raffoul of the University of Toronto, algorithms on social media platforms may increasingly push weight-loss and appearance-focused content, even to users who do not actively seek it, potentially fostering harmful diet cultures. The fashion industry may face ongoing scrutiny from health organizations and body positivity advocates regarding its promotion of thinness and its partnerships with pharmaceutical companies. Brands might need to navigate public relations challenges as they balance commercial interests with social responsibility. The conversation around body image may also evolve, with concepts like 'body neutrality' gaining traction as an alternative to the pressures of both extreme thinness and prescriptive body positivity, focusing instead on personal worth beyond physical appearance.
Beyond the Headlines
The return of extreme thinness in fashion reflects deeper societal currents, including the evolving relationship between technology, health, and personal identity. The widespread availability and discussion of GLP-1 drugs introduce a new dimension to body image, potentially normalizing pharmaceutical interventions for weight management in ways that extend beyond medical necessity. This could lead to ethical debates about the medicalization of aesthetics and the long-term societal impact of widespread drug use for cosmetic purposes. Furthermore, the fashion industry's historical pattern of co-opting social movements, as observed by Tigress Osborn, highlights a persistent challenge: how genuine social change can be distinguished from marketing strategies. The shift in language from overt thinness to terms like 'fitness' and 'healthy lifestyle' on social media and in advertising represents a subtle but significant cultural re-framing, potentially masking traditional pressures under the guise of wellness. This linguistic shift could make it harder for individuals to identify and resist harmful body ideals, as the pursuit of thinness becomes intertwined with seemingly positive health narratives.
